Axcelis designs and supplies ion-implantation equipment, including the Purion platform, used to manufacture silicon and silicon-carbide semiconductor devices.
Axcelis makes ion implantation systems, one of the enabling front-end steps in IC manufacturing, and has operated for over 45 years. Chinese regulator filings assessed its share of the global and Chinese ion implantation markets at 20 to 25 percent in 2024, which is a third-party read on position rather than a company claim. FY2025 revenue was USD 839.0 million against USD 1,017.9 million in FY2024, with gross margin 44.9 percent, net income USD 120.2 million and diluted EPS USD 3.80; the decline reflects cyclical digestion in Power and General Mature markets partly offset by record customer service and installed base revenue. In the second quarter of 2026 revenue was USD 215.2 million, backlog stood at USD 452 million, China was 46 percent of quarterly revenue, and the company raised FY2026 guidance to mid-single-digit revenue growth. The pending all-stock merger with Veeco, announced in October 2025 at approximately USD 4.4 billion enterprise value, would make Veeco a wholly owned subsidiary of Axcelis, with Axcelis holders at approximately 58 percent, headquarters in Beverly and a new name, ticker and brand after close. Shareholder approvals were obtained on 2026-02-06 and the final outstanding condition is clearance from China SAMR.
12 signals name Axcelis Technologies. Members see all of them, filtered by topic, source and date.
27 facts on file. Members see all of them with the source link.
Traction: deployment, production, commercials, progress. Capability: technology, positioning, firepower, leverage.
Axcelis designs and supplies ion-implantation equipment, including the Purion platform, used to manufacture silicon and silicon-carbide semiconductor devices. Axcelis makes ion implantation systems, one of the enabling front-end steps in IC manufacturing, and has operated for over 45 years. Chinese regulator filings assessed its share of the global and Chinese ion implantation markets at 20 to 25 percent in 2024, which is a third-party read on position rather than a company claim. FY2025 revenue was USD 839.0 million against USD 1,017.9 million in FY202
Axcelis Technologies is on the AI Core watchlist list of Frontier Tech Intelligence with a score of 81 out of 100, below the Top 100.
Axcelis Technologies is based in Beverly, Massachusetts, United States.
Subscribers see the full file, every signal, the live ranking and the questions the signals answer: where money moved, who controls the layer, where supply is constrained. $99 a month, 7-day trial. What Frontier Tech Intelligence is →